Danaher Corporation (DHR) — insider trading
Health Care
Danaher Corporation (DHR) has 24 reported SEC Form 4 insider transactions in our data (latest 2026-07-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | Zerhouni Elias A. | Director | Option exercise / conversion (derivative) | 3,298 | $0.00 | $0 | Form 4 |
| 2026-07-15 | Zerhouni Elias A. | Director | Shares withheld for taxes / exercise cost | 1,181 | $200.79 | $237.1K | Form 4 |
| 2026-07-15 | Zerhouni Elias A. | Director | Option exercise / conversion | 3,298 | $71.88 | $237.1K | Form 4 |
| 2026-07-15 | FILLER LINDA | Director | Option exercise / conversion (derivative) | 3,298 | $0.00 | $0 | Form 4 |
| 2026-07-15 | FILLER LINDA | Director | Shares withheld for taxes / exercise cost | 1,181 | $200.79 | $237.1K | Form 4 |
| 2026-07-15 | FILLER LINDA | Director | Option exercise / conversion | 3,298 | $71.88 | $237.1K | Form 4 |
| 2026-07-15 | Bouda Christopher | Officer (VP, Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 60 | $200.79 | $12.0K | Form 4 |
| 2026-05-15 | Lamanna Charles W | Director | Grant / award / vesting (derivative) | 1,699 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Lamanna Charles W | Director | Grant / award / vesting | 680 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Dewan Feroz | Director | Grant / award / vesting (derivative) | 1,699 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Dewan Feroz | Director | Grant / award / vesting | 680 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Zerhouni Elias A. | Director | Grant / award / vesting (derivative) | 1,699 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Zerhouni Elias A. | Director | Grant / award / vesting | 680 | $0.00 | $0 | Form 4 |
| 2026-05-15 | List Teri | Director | Grant / award / vesting (derivative) | 1,699 | $0.00 | $0 | Form 4 |
| 2026-05-15 | List Teri | Director | Grant / award / vesting | 680 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Sanders A Shane | Director | Grant / award / vesting (derivative) | 1,699 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Sanders A Shane | Director | Grant / award / vesting | 680 | $0.00 | $0 | Form 4 |
| 2026-05-15 | SPOON ALAN G | Director | Grant / award / vesting (derivative) | 1,699 | $0.00 | $0 | Form 4 |
| 2026-05-15 | SPOON ALAN G | Director | Grant / award / vesting | 680 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Stevens Raymond C | Director | Grant / award / vesting (derivative) | 1,699 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Stevens Raymond C | Director | Grant / award / vesting | 680 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Couchara Georgeann | Officer (SVP, Human Resources) | Shares withheld for taxes / exercise cost | 281 | $161.91 | $45.5K | Form 4 |
| 2026-05-15 | FILLER LINDA | Director | Grant / award / vesting (derivative) | 1,699 | $0.00 | $0 | Form 4 |
| 2026-05-15 | FILLER LINDA | Director | Grant / award / vesting | 680 | $0.00 | $0 | Form 4 |
Ask the chat about DHR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Danaher Corporation (DHR).
Last updated 2026-07-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.